MNC firms unhappy over Govt. move to put curbs on FDI in pharma sector

摘要

India's attempts to check foreign investment in pharma sector and expand drug pricing control could force multinationals to exit the country, according to Mr. Kewal Handa, Managing Director, Pfizer India."India might not become attractive market if we have such controls,you will see companies pulling out of India," he said. "It's the attractiveness of the domestic business that attracts investment. All global companies have their options open. You will not put money where the opportunity is less, and we do not have the right ecosystem lor investments in pharma," he added.